You have free access to this content

Hepatology

Cover image for Hepatology

March 2008

Volume 47, Issue 3

Pages 771–1102

  1. Comments from the Editors

    1. Top of page
    2. Comments from the Editors
    3. Presidential Profile
    4. Master's Perspective
    5. Editorial
    6. Viral Hepatitis
    7. Steatohepatitis/Metabolic Liver Disease
    8. Hepatobiliary Malignancies
    9. Autoimmune, Cholestatic and Billiary Disease
    10. Autoimmune, Cholestatic and Biliary Disease
    11. Liver Failure/Cirrhosis/Portal Hypertension
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Special Article
    15. Reviews
    16. Hepatology Elsewhere
    17. Correspondence
    18. Corrections
    1. You have free access to this content
  2. Presidential Profile

    1. Top of page
    2. Comments from the Editors
    3. Presidential Profile
    4. Master's Perspective
    5. Editorial
    6. Viral Hepatitis
    7. Steatohepatitis/Metabolic Liver Disease
    8. Hepatobiliary Malignancies
    9. Autoimmune, Cholestatic and Billiary Disease
    10. Autoimmune, Cholestatic and Biliary Disease
    11. Liver Failure/Cirrhosis/Portal Hypertension
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Special Article
    15. Reviews
    16. Hepatology Elsewhere
    17. Correspondence
    18. Corrections
    1. You have free access to this content
      Arthur Joseph McCullough, Jr., 58th President, AASLD (pages 775–776)

      Albert J. Czaja and Anthony S. Tavill

      Version of Record online: 27 FEB 2008 | DOI: 10.1002/hep.22666

  3. Master's Perspective

    1. Top of page
    2. Comments from the Editors
    3. Presidential Profile
    4. Master's Perspective
    5. Editorial
    6. Viral Hepatitis
    7. Steatohepatitis/Metabolic Liver Disease
    8. Hepatobiliary Malignancies
    9. Autoimmune, Cholestatic and Billiary Disease
    10. Autoimmune, Cholestatic and Biliary Disease
    11. Liver Failure/Cirrhosis/Portal Hypertension
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Special Article
    15. Reviews
    16. Hepatology Elsewhere
    17. Correspondence
    18. Corrections
    1. You have free access to this content
  4. Editorial

    1. Top of page
    2. Comments from the Editors
    3. Presidential Profile
    4. Master's Perspective
    5. Editorial
    6. Viral Hepatitis
    7. Steatohepatitis/Metabolic Liver Disease
    8. Hepatobiliary Malignancies
    9. Autoimmune, Cholestatic and Billiary Disease
    10. Autoimmune, Cholestatic and Biliary Disease
    11. Liver Failure/Cirrhosis/Portal Hypertension
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Special Article
    15. Reviews
    16. Hepatology Elsewhere
    17. Correspondence
    18. Corrections
    1. You have free access to this content
      Significance of autoantibodies (pages 786–788)

      Johannes Herkel and Ansgar W. Lohse

      Version of Record online: 7 FEB 2008 | DOI: 10.1002/hep.22271

  5. Viral Hepatitis

    1. Top of page
    2. Comments from the Editors
    3. Presidential Profile
    4. Master's Perspective
    5. Editorial
    6. Viral Hepatitis
    7. Steatohepatitis/Metabolic Liver Disease
    8. Hepatobiliary Malignancies
    9. Autoimmune, Cholestatic and Billiary Disease
    10. Autoimmune, Cholestatic and Biliary Disease
    11. Liver Failure/Cirrhosis/Portal Hypertension
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Special Article
    15. Reviews
    16. Hepatology Elsewhere
    17. Correspondence
    18. Corrections
    1. You have free access to this content
      Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C (pages 789–798)

      Robert J. Fontana, Zachary D. Goodman, Jules L. Dienstag, Herbert L. Bonkovsky, Deepa Naishadham, Richard K. Sterling, Grace L. Su, Mita Ghosh, Elizabeth C. Wright and HALT-C Trial Group

      Version of Record online: 3 JAN 2008 | DOI: 10.1002/hep.22099

    2. You have free access to this content
      Interferon regulatory factor-3 activation, hepatic interferon-stimulated gene expression, and immune cell infiltration in hepatitis C virus patients (pages 799–809)

      Daryl T.-Y. Lau, Penny Mar Fish, Mala Sinha, David M. Owen, Stanley M. Lemon and Michael Gale Jr

      Version of Record online: 17 JAN 2008 | DOI: 10.1002/hep.22076

    3. You have free access to this content
      Optical analysis of computed tomography images of the liver predicts fibrosis stage and distribution in chronic hepatitis C (pages 810–816)

      Manuel Romero-Gómez, Emilio Gómez-González, Ana Madrazo, Marina Vera-Valencia, Luis Rodrigo, Ramón Pérez-Alvarez, Rosa Pérez-López, Victor M. Castellano-Megias, Manuel Nevado-Santos, Juan C. Alcón, Ricard Solá, José M. Pérez-Moreno, José M. Navarro, Raúl J. Andrade, Javier Salmerón, Manuel Fernández-López, Rafael Aznar and Moisés Diago

      Version of Record online: 20 DEC 2007 | DOI: 10.1002/hep.22112

    4. You have free access to this content
      The cyclophilin inhibitor Debio-025 shows potent anti–hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus (pages 817–826)

      Robert Flisiak, Andrzej Horban, Philippe Gallay, Michael Bobardt, Suganya Selvarajah, Alicja Wiercinska-Drapalo, Ewa Siwak, Iwona Cielniak, Jozef Higersberger, Jarek Kierkus, Christian Aeschlimann, Pierre Grosgurin, Valérie Nicolas-Métral, Jean-Maurice Dumont, Hervé Porchet, Raf Crabbé and Pietro Scalfaro

      Version of Record online: 7 JAN 2008 | DOI: 10.1002/hep.22131

    5. You have free access to this content
      The nucleotide binding motif of hepatitis C virus NS4B can mediate cellular transformation and tumor formation without Ha-ras co-transfection (pages 827–835)

      Shirit Einav, Ella H. Sklan, Hyang Mi Moon, Elizabeth Gehrig, Ping Liu, Ying Hao, Anson W. Lowe and Jeffrey S. Glenn

      Version of Record online: 14 DEC 2007 | DOI: 10.1002/hep.22108

    6. You have free access to this content
      Pathology of chronic hepatitis C in children: Liver biopsy findings in the Peds-C Trial (pages 836–843)

      Zachary D. Goodman, Hala R. Makhlouf, Lea Liu, William Balistreri, Regino P. Gonzalez-Peralta, Barbara Haber, Maureen M. Jonas, Parvathi Mohan, Jean P. Molleston, Karen F. Murray, Michael R. Narkewicz, Philip Rosenthal, Lesley J. Smith, Patricia R. Robuck and Kathleen B. Schwarz

      Version of Record online: 31 DEC 2007 | DOI: 10.1002/hep.22094

    7. You have free access to this content
      A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial (pages 844–853)

      Chiun Hsu, Chao A. Hsiung, Ih-Jen Su, Wei-Shou Hwang, Ming-Chung Wang, Sheng-Fung Lin, Tseng-Hsi Lin, Hui-Hua Hsiao, Ji-Hsiung Young, Ming-Chih Chang, Yu-Min Liao, Chi-Cheng Li, Hung-Bo Wu, Hwei-Fang Tien, Tsu-Yi Chao, Tsang-Wu Liu, Ann-Lii Cheng and Pei-Jer Chen

      Version of Record online: 27 DEC 2007 | DOI: 10.1002/hep.22106

    8. You have free access to this content
      A molecular chaperone glucose-regulated protein 94 blocks apoptosis induced by virus infection (pages 854–866)

      Song Hee Lee, Ran Song, Mi Nam Lee, Chon Saeng Kim, Hanna Lee, Young-Yun Kong, Hoguen Kim and Sung Key Jang

      Version of Record online: 7 JAN 2008 | DOI: 10.1002/hep.22107

  6. Steatohepatitis/Metabolic Liver Disease

    1. Top of page
    2. Comments from the Editors
    3. Presidential Profile
    4. Master's Perspective
    5. Editorial
    6. Viral Hepatitis
    7. Steatohepatitis/Metabolic Liver Disease
    8. Hepatobiliary Malignancies
    9. Autoimmune, Cholestatic and Billiary Disease
    10. Autoimmune, Cholestatic and Biliary Disease
    11. Liver Failure/Cirrhosis/Portal Hypertension
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Special Article
    15. Reviews
    16. Hepatology Elsewhere
    17. Correspondence
    18. Corrections
    1. You have free access to this content
      Inhibition of adiponectin production by homocysteine: A potential mechanism for alcoholic liver disease (pages 867–879)

      Zhenyuan Song, Zhanxiang Zhou, Ion Deaciuc, Theresa Chen and Craig J. McClain

      Version of Record online: 31 DEC 2007 | DOI: 10.1002/hep.22074

    2. You have free access to this content
      Serum aminotransferase activity and mortality risk in a United States community (pages 880–887)

      Tae Hoon Lee, W. Ray Kim, Joanne T. Benson, Terry M. Therneau and L. Joseph Melton III

      Version of Record online: 7 JAN 2008 | DOI: 10.1002/hep.22090

  7. Hepatobiliary Malignancies

    1. Top of page
    2. Comments from the Editors
    3. Presidential Profile
    4. Master's Perspective
    5. Editorial
    6. Viral Hepatitis
    7. Steatohepatitis/Metabolic Liver Disease
    8. Hepatobiliary Malignancies
    9. Autoimmune, Cholestatic and Billiary Disease
    10. Autoimmune, Cholestatic and Biliary Disease
    11. Liver Failure/Cirrhosis/Portal Hypertension
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Special Article
    15. Reviews
    16. Hepatology Elsewhere
    17. Correspondence
    18. Corrections
    1. You have free access to this content
      Activation-induced cytidine deaminase links bile duct inflammation to human cholangiocarcinoma (pages 888–896)

      Junji Komori, Hiroyuki Marusawa, Takafumi Machimoto, Yoko Endo, Kazuo Kinoshita, Tadayuki Kou, Hironori Haga, Iwao Ikai, Shinji Uemoto and Tsutomu Chiba

      Version of Record online: 27 FEB 2008 | DOI: 10.1002/hep.22125

    2. You have free access to this content
      Identification of metastasis-related microRNAs in hepatocellular carcinoma (pages 897–907)

      Anuradha Budhu, Hu-Liang Jia, Marshonna Forgues, Chang-Gong Liu, David Goldstein, Amy Lam, Krista A. Zanetti, Qing-Hai Ye, Lun-Xiu Qin, Carlo M. Croce, Zhao-You Tang and Xin Wei Wang

      Version of Record online: 6 JAN 2008 | DOI: 10.1002/hep.22160

    3. You have free access to this content
      Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma (pages 908–918)

      Naoshi Nishida, Takeshi Nagasaka, Takafumi Nishimura, Iwao Ikai, C. Richard Boland and Ajay Goel

      Version of Record online: 26 DEC 2007 | DOI: 10.1002/hep.22110

    4. You have free access to this content
      Identification of local and circulating cancer stem cells in human liver cancer (pages 919–928)

      Zhen Fan Yang, Patricia Ngai, David W. Ho, Wan Ching Yu, Michael N.P. Ng, Chi Keung Lau, Mandy L. Y. Li, Ka Ho Tam, Chi Tat Lam, Ronnie T. P. Poon and Sheung Tat Fan

      Version of Record online: 14 FEB 2008 | DOI: 10.1002/hep.22082

    5. You have free access to this content
      Metastatic tumor antigen 1 is closely associated with frequent postoperative recurrence and poor survival in patients with hepatocellular carcinoma (pages 929–936)

      Soo Hyung Ryu, Young-Hwa Chung, Hyunseung Lee, Jeong A. Kim, Hyun Deok Shin, Hyun Joo Min, Dong Dae Seo, Myoung Kuk Jang, Eunsil Yu and Kyu-Won Kim

      Version of Record online: 27 FEB 2008 | DOI: 10.1002/hep.22124

  8. Autoimmune, Cholestatic and Billiary Disease

    1. Top of page
    2. Comments from the Editors
    3. Presidential Profile
    4. Master's Perspective
    5. Editorial
    6. Viral Hepatitis
    7. Steatohepatitis/Metabolic Liver Disease
    8. Hepatobiliary Malignancies
    9. Autoimmune, Cholestatic and Billiary Disease
    10. Autoimmune, Cholestatic and Biliary Disease
    11. Liver Failure/Cirrhosis/Portal Hypertension
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Special Article
    15. Reviews
    16. Hepatology Elsewhere
    17. Correspondence
    18. Corrections
    1. You have free access to this content
      Identification of plasma membrane autoantigens in autoimmune hepatitis type 1 using a proteomics tool (pages 937–948)

      Fatima Tahiri, François Le Naour, Stéphanie Huguet, René Lai-Kuen, Didier Samuel, Catherine Johanet, Bruno Saubamea, Viviane Tricottet, Jean-Charles Duclos-Vallee and Eric Ballot

      Version of Record online: 27 FEB 2008 | DOI: 10.1002/hep.22149

  9. Autoimmune, Cholestatic and Biliary Disease

    1. Top of page
    2. Comments from the Editors
    3. Presidential Profile
    4. Master's Perspective
    5. Editorial
    6. Viral Hepatitis
    7. Steatohepatitis/Metabolic Liver Disease
    8. Hepatobiliary Malignancies
    9. Autoimmune, Cholestatic and Billiary Disease
    10. Autoimmune, Cholestatic and Biliary Disease
    11. Liver Failure/Cirrhosis/Portal Hypertension
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Special Article
    15. Reviews
    16. Hepatology Elsewhere
    17. Correspondence
    18. Corrections
    1. You have free access to this content
      Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: Evaluating the role of routine magnetic resonance imaging (pages 949–957)

      Rupert Abdalian, Preeti Dhar, Kartik Jhaveri, Masoom Haider, Maha Guindi and E. Jenny Heathcote

      Version of Record online: 27 DEC 2007 | DOI: 10.1002/hep.22073

    2. You have free access to this content
      Biliary epithelial cells and primary biliary cirrhosis: The role of liver-infiltrating mononuclear cells (pages 958–965)

      Shinji Shimoda, Kenichi Harada, Hiroaki Niiro, Tomoharu Yoshizumi, Yuji Soejima, Akinobu Taketomi, Yoshihiko Maehara, Koichi Tsuneyama, Minoru Nakamura, Atsumasa Komori, Kiyoshi Migita, Yasuni Nakanuma, Hiromi Ishibashi, Carlo Selmi and M. Eric Gershwin

      Version of Record online: 7 JAN 2008 | DOI: 10.1002/hep.22102

  10. Liver Failure/Cirrhosis/Portal Hypertension

    1. Top of page
    2. Comments from the Editors
    3. Presidential Profile
    4. Master's Perspective
    5. Editorial
    6. Viral Hepatitis
    7. Steatohepatitis/Metabolic Liver Disease
    8. Hepatobiliary Malignancies
    9. Autoimmune, Cholestatic and Billiary Disease
    10. Autoimmune, Cholestatic and Biliary Disease
    11. Liver Failure/Cirrhosis/Portal Hypertension
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Special Article
    15. Reviews
    16. Hepatology Elsewhere
    17. Correspondence
    18. Corrections
    1. You have free access to this content
      Defective endothelial nitric oxide synthase signaling is mediated by rho-kinase activation in rats with secondary biliary cirrhosis (pages 966–977)

      Go Anegawa, Hirofumi Kawanaka, Daisuke Yoshida, Kozo Konishi, Shohei Yamaguchi, Nao Kinjo, Akinobu Taketomi, Makoto Hashizume, Hiroaki Shimokawa and Yoshihiko Maehara

      Version of Record online: 31 DEC 2007 | DOI: 10.1002/hep.22089

    2. You have free access to this content
      Bacterial DNA in patients with cirrhosis and noninfected ascites mimics the soluble immune response established in patients with spontaneous bacterial peritonitis (pages 978–985)

      Rubén Francés, Pedro Zapater, José M. González-Navajas, Carlos Muñoz, Rocío Caño, Rocío Moreu, Sonia Pascual, Pablo Bellot, Miguel Pérez-Mateo and José Such

      Version of Record online: 27 FEB 2008 | DOI: 10.1002/hep.22083

  11. Liver Injury/Regeneration

    1. Top of page
    2. Comments from the Editors
    3. Presidential Profile
    4. Master's Perspective
    5. Editorial
    6. Viral Hepatitis
    7. Steatohepatitis/Metabolic Liver Disease
    8. Hepatobiliary Malignancies
    9. Autoimmune, Cholestatic and Billiary Disease
    10. Autoimmune, Cholestatic and Biliary Disease
    11. Liver Failure/Cirrhosis/Portal Hypertension
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Special Article
    15. Reviews
    16. Hepatology Elsewhere
    17. Correspondence
    18. Corrections
    1. You have free access to this content
      Isolation and functional identification of a novel human hepatic growth factor: Hepatopoietin Cn (pages 986–995)

      Chun-Ping Cui, Da-Jin Zhang, Bing-Xing Shi, Shao-Jun Du, Dan-Li Wu, Ping Wei, Gen-Shen Zhong, Zi-Kuan Guo, Yang Liu, Li-Sheng Wang and Chu-Tse Wu

      Version of Record online: 27 FEB 2008 | DOI: 10.1002/hep.22126

    2. You have free access to this content
      Connective tissue growth factor with a novel fibronectin binding site promotes cell adhesion and migration during rat oval cell activation (pages 996–1004)

      Liya Pi, Xiaodong Ding, Marda Jorgensen, Jen-Jung Pan, Seh-Hoon Oh, Dana Pintilie, Alicia Brown, Wen-Yuan Song and Bryon E. Petersen

      Version of Record online: 31 DEC 2007 | DOI: 10.1002/hep.22079

    3. You have free access to this content
  12. Liver Biology/Pathobiology

    1. Top of page
    2. Comments from the Editors
    3. Presidential Profile
    4. Master's Perspective
    5. Editorial
    6. Viral Hepatitis
    7. Steatohepatitis/Metabolic Liver Disease
    8. Hepatobiliary Malignancies
    9. Autoimmune, Cholestatic and Billiary Disease
    10. Autoimmune, Cholestatic and Biliary Disease
    11. Liver Failure/Cirrhosis/Portal Hypertension
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Special Article
    15. Reviews
    16. Hepatology Elsewhere
    17. Correspondence
    18. Corrections
    1. You have free access to this content
      Wnt2 acts as a cell type–specific, autocrine growth factor in rat hepatic sinusoidal endothelial cells cross-stimulating the VEGF pathway (pages 1018–1031)

      Diana Klein, Alexandra Demory, Francis Peyre, Jens Kroll, Hellmut G. Augustin, Wijnand Helfrich, Julia Kzhyshkowska, Kai Schledzewski, Bernd Arnold and Sergij Goerdt

      Version of Record online: 27 DEC 2007 | DOI: 10.1002/hep.22084

    2. You have free access to this content
      Inhibition of mitochondrial fatty acid oxidation in vivo only slightly suppresses gluconeogenesis but enhances clearance of glucose in mice (pages 1032–1042)

      Terry G. J. Derks, Theo H. van Dijk, Aldo Grefhorst, Jan-Peter Rake, G. Peter A. Smit, Folkert Kuipers and Dirk-Jan Reijngoud

      Version of Record online: 7 JAN 2008 | DOI: 10.1002/hep.22101

    3. You have free access to this content
      Comprehensive and quantitative proteome profiling of the mouse liver and plasma (pages 1043–1051)

      Keane K. Y. Lai, Deepak Kolippakkam and Laura Beretta

      Version of Record online: 11 FEB 2008 | DOI: 10.1002/hep.22123

  13. Special Article

    1. Top of page
    2. Comments from the Editors
    3. Presidential Profile
    4. Master's Perspective
    5. Editorial
    6. Viral Hepatitis
    7. Steatohepatitis/Metabolic Liver Disease
    8. Hepatobiliary Malignancies
    9. Autoimmune, Cholestatic and Billiary Disease
    10. Autoimmune, Cholestatic and Biliary Disease
    11. Liver Failure/Cirrhosis/Portal Hypertension
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Special Article
    15. Reviews
    16. Hepatology Elsewhere
    17. Correspondence
    18. Corrections
    1. You have free access to this content
  14. Reviews

    1. Top of page
    2. Comments from the Editors
    3. Presidential Profile
    4. Master's Perspective
    5. Editorial
    6. Viral Hepatitis
    7. Steatohepatitis/Metabolic Liver Disease
    8. Hepatobiliary Malignancies
    9. Autoimmune, Cholestatic and Billiary Disease
    10. Autoimmune, Cholestatic and Biliary Disease
    11. Liver Failure/Cirrhosis/Portal Hypertension
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Special Article
    15. Reviews
    16. Hepatology Elsewhere
    17. Correspondence
    18. Corrections
    1. You have free access to this content
    2. You have free access to this content
      Liver disease in pregnancy (pages 1067–1076)

      J. Eileen Hay

      Version of Record online: 10 JAN 2008 | DOI: 10.1002/hep.22130

    3. You have free access to this content
      Biology and pathobiology of gap junctional channels in hepatocytes (pages 1077–1088)

      Mathieu Vinken, Tom Henkens, Evelien De Rop, Joanna Fraczek, Tamara Vanhaecke and Vera Rogiers

      Version of Record online: 3 DEC 2007 | DOI: 10.1002/hep.22049

  15. Hepatology Elsewhere

    1. Top of page
    2. Comments from the Editors
    3. Presidential Profile
    4. Master's Perspective
    5. Editorial
    6. Viral Hepatitis
    7. Steatohepatitis/Metabolic Liver Disease
    8. Hepatobiliary Malignancies
    9. Autoimmune, Cholestatic and Billiary Disease
    10. Autoimmune, Cholestatic and Biliary Disease
    11. Liver Failure/Cirrhosis/Portal Hypertension
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Special Article
    15. Reviews
    16. Hepatology Elsewhere
    17. Correspondence
    18. Corrections
    1. You have free access to this content
    2. You have free access to this content
      Control of HCV replication: When size does not matter (pages 1092–1094)

      Michael R. Beard and Karla J. Helbig

      Version of Record online: 7 FEB 2008 | DOI: 10.1002/hep.22267

  16. Correspondence

    1. Top of page
    2. Comments from the Editors
    3. Presidential Profile
    4. Master's Perspective
    5. Editorial
    6. Viral Hepatitis
    7. Steatohepatitis/Metabolic Liver Disease
    8. Hepatobiliary Malignancies
    9. Autoimmune, Cholestatic and Billiary Disease
    10. Autoimmune, Cholestatic and Biliary Disease
    11. Liver Failure/Cirrhosis/Portal Hypertension
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Special Article
    15. Reviews
    16. Hepatology Elsewhere
    17. Correspondence
    18. Corrections
    1. You have free access to this content
      TGF-β and hepatocellular carcinoma (page 1095)

      Marina Bortolami, Romilda Cardin, Andromachi Kotsafti and Fabio Farinati

      Version of Record online: 27 FEB 2008 | DOI: 10.1002/hep.22156

    2. You have free access to this content
      Reply: (pages 1095–1096)

      Koichi Matsuzaki and Iwata Ozaki

      Version of Record online: 27 FEB 2008 | DOI: 10.1002/hep.22199

    3. You have free access to this content
      Disease-specific autoantibodies in patients with acute liver failure: The King's College London Experience (pages 1096–1097)

      William Bernal, Francesca Meda, Yun Ma, Dimitrios P. Bogdanos and Diego Vergani

      Version of Record online: 27 FEB 2008 | DOI: 10.1002/hep.22179

    4. You have free access to this content
      Reply: (page 1097)

      M. Eric Gershwin

      Version of Record online: 27 FEB 2008 | DOI: 10.1002/hep.22305

    5. You have free access to this content
    6. You have free access to this content
      Reply: (page 1098)

      Zhiping Li

      Version of Record online: 27 FEB 2008 | DOI: 10.1002/hep.22186

    7. You have free access to this content
      AASLD public policy statement should be evidence-based (page 1098)

      Edwin K. Kuffner and Jeffrey S. Baggish

      Version of Record online: 27 FEB 2008 | DOI: 10.1002/hep.22133

    8. You have free access to this content
      Reply: (pages 1098–1099)

      William M. Lee

      Version of Record online: 27 FEB 2008 | DOI: 10.1002/hep.22209

    9. You have free access to this content
    10. You have free access to this content
      Reply: (page 1100)

      Dominique Thabut, Khalid Tazi, Dominique Bonnefont-Rousselot, Richard Moreau and Didier Lebrec

      Version of Record online: 27 FEB 2008 | DOI: 10.1002/hep.22234

    11. You have free access to this content
      The use of enzyme results for liver fibrosis evaluation neccessitates standardization (pages 1100–1101)

      Anne Myara, Jérôme Guechot, Elisabeth Lasnier, Françoise Imbert-Bismut, Hélène Voitot and Georges Ferard

      Version of Record online: 11 FEB 2008 | DOI: 10.1002/hep.22128

  17. Corrections

    1. Top of page
    2. Comments from the Editors
    3. Presidential Profile
    4. Master's Perspective
    5. Editorial
    6. Viral Hepatitis
    7. Steatohepatitis/Metabolic Liver Disease
    8. Hepatobiliary Malignancies
    9. Autoimmune, Cholestatic and Billiary Disease
    10. Autoimmune, Cholestatic and Biliary Disease
    11. Liver Failure/Cirrhosis/Portal Hypertension
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Special Article
    15. Reviews
    16. Hepatology Elsewhere
    17. Correspondence
    18. Corrections
    1. You have free access to this content
      Correction (pages 1102–1103)

      Version of Record online: 14 FEB 2008 | DOI: 10.1002/hep.22230

    2. You have free access to this content
      Correction (page 1102)

      Version of Record online: 27 FEB 2008 | DOI: 10.1002/hep.22257

    3. You have free access to this content
      Correction (page 1102)

      Version of Record online: 27 FEB 2008 | DOI: 10.1002/hep.22258

SEARCH

SEARCH BY CITATION